San Francisco, California (PRWEB) September 15, 2014
QURE Healthcare is very pleased to announce the appointment of Trever Burgon, PhD as company Vice President. Dr. Burgon is a nationally recognized leader in health care transformation and strategy. He has worked extensively with hospital systems and life science companies, QURE’s two business sectors, on projects across the country ranging from value-based payment structures and future demand forecasting to cancer center development and clinical technology assessment.
As QURE Healthcare continues its rapid growth, Dr. Burgon will direct the company’s expansion into hospital and life science markets where many partners have come to trust his perspective and guidance. Dr. Burgon’s hands-on knowledge will guide the practical implementation of QURE’s Clinical Performance and Value (CPV®) vignettes, which benchmark clinical variation and produce practice change.
“We are thrilled to welcome Dr. Burgon and have his experience, personable style and leadership added to the QURE team,” said Dr. John Peabody, QURE’s President and Founder. “Trever’s attention to detail, deep scientific knowledge and innovative thinking will contribute enormously to QURE’s vision to be the global leader in healthcare quality measurement. Dr. Burgon’s hire, and our growing list of provider and life science clients, are accomplishing that vision by addressing significant clinical quality and cost issues in the marketplace.”
“My experience has shown me that successfully engaging physicians is critical to making meaningful and sustainable improvements in health care,” said Dr Burgon. “QURE’s elegant and unique solution to measure, benchmark and align care with evidence-based guidelines addresses a real unmet need in health care today. I am excited to be part of a team tackling these critically important issues.”
Dr. Peabody added, “Recently QURE has formed strategic partnerships with some of the most thoughtful Fortune 500 companies. As we grow in this area we needed additional senior leadership at QURE to guide these vital relationships—relationships we expect to help QURE transform clinical care in every hospital and every sector we engage.”
About Trever Burgon, PhD
Dr. Burgon comes most recently from Sg2, a Skokie IL based health care analytics and information firm. At Sg2, Trever served as Vice President and led the company’s Center for Clinical Technology as well as the Oncology Strategy team. Trever speaks frequently at national conferences on issues on quality and value in healthcare. Trever holds a PhD from Stanford University in Microbiology and Immunology and received his Bachelors of Science, graduating summa cum laude with university honors, from Brigham Young University.
About QURE Healthcare
QURE Healthcare is a research and business strategy firm committed to improving the quality of clinical care. QURE uses its proprietary software technology, CPV® (Clinical Performance and Value) vignettes, to evaluate clinical practice and the cost-effectiveness of health care services at the level of individual physicians and other health care providers. CPV® vignettes are used in health systems in the US and over 30 countries worldwide. Core services include CPV® studies, health economic analyses, and physician-level data collection. The ease, validity and affordability of CPV® vignettes attract a wide array of clients: payers, hospital systems, life science firms, medical technology companies, medical licensing and education institutions as well as international health development organizations. For more information visit LinkedIn (https://www.linkedin.com/company/qure-healthcare), Twitter (https://twitter.com/QURE_Healthcare) or the QURE homepage (http://www.qurehealthcare.com).